Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Cyclosporine emulsion offers severe dry eye relief
April 14-San Francisco-Cyclosporine ophthalmic emulsion 0.05% drops (Restasis,Allergan), approved 11 days ago, offers relief of dry eye symptoms by treatingthe inflammatory process that causes the condition, explained John D. Sheppard,MD, program and laboratory director, professor, departments of ophthalmologyand pharmacology, Eastern Virginia School of Medicine. He spoke during thesymposium, "Interdisciplinary Perspectives in Corneal Health Integrity,"sponsored by Allergan.
Related Videos
Related Content
